No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Lenalidomide is an immunomodulatory drug used in the treatment of multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. It is a derivative of thalidomide, and works by inhibiting tumor growth and angiogenesis. Lenalidomide is also used to treat anemia, a common symptom of cancer. It is taken orally, and is available in both capsule and tablet form.
Lenalidomide is a relatively new drug, and is still in the process of being approved for use in many countries. It is currently approved in the United States, Canada, Europe, Australia, and other countries. It is also being studied for use in other types of cancer, such as breast cancer and non-Hodgkin's lymphoma.
Lenalidomide is a highly effective drug, and is often used in combination with other drugs to treat cancer. It is also used in combination with chemotherapy and radiation therapy.
Lenalidomide is marketed by several companies, including Celgene, Teva Pharmaceuticals, and Mylan. It is also available in generic form from several generic drug manufacturers. Show Less Read more
